Durvalumab Plus FLOT Ups Survival in Early Upper-GI Cancer – Medscape

  1. Durvalumab Plus FLOT Ups Survival in Early Upper-GI Cancer  Medscape
  2. AstraZeneca, Inc. Announces Positive Results from the Matterorn Phase III Trial  MarketScreener
  3. Imfinzi Plus Chemo Improves Survival in G/GEJ Adenocarcinoma  CUREtoday.com

Continue Reading